Ftse Mib
33.266,39
1,09%
DAX
18.157,18
0,46%
S&P 500
5.473,23
0,77%
NASDAQ
17.857,02
0,95%
Bitcoin
65.687,07
-1,21%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Iterum Therapeutics PLC (ITRM) Iterum Therapeutics PLC (ITRM) Notizie

Iterum Therapeutics PLC

ITRM
1,13
0,00 (0,00%)
18 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/6/202422:11EDGAR2Form S-1 - General form for registration of securities under..
05/6/202414:00GLOBEIterum Therapeutics to Present Data at ASM Microbe 2024
31/5/202414:30EDGAR2Form 8-K - Current report
31/5/202414:00GLOBEIterum Therapeutics Receives FDA Acceptance of Resubmission..
13/5/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202413:15EDGAR2Form 8-K - Current report
13/5/202413:00GLOBEIterum Therapeutics Reports First Quarter 2024 Financial..
06/5/202414:00GLOBEIterum Therapeutics to Report First Quarter 2024 Financial..
29/4/202414:00GLOBEIterum Therapeutics Resubmits New Drug Application to U.S...
28/3/202412:42IHMARKETNEWSUS Stock Futures Stable in Pre-Market On Path for..
28/3/202412:00GLOBEIterum Therapeutics Reports Fourth Quarter and Full Year..
21/3/202421:30GLOBEIterum Therapeutics to Report Fourth Quarter and Full Year..
15/3/202413:00GLOBEIterum Therapeutics to Participate in H.C. Wainwright..
06/3/202414:16EDGAR2Form 8-K - Current report
06/3/202414:00GLOBEIterum Therapeutics Provides Business Update
30/1/202423:00EDGAR2Form 8-K - Current report
30/1/202413:15EDGAR2Form 8-K - Current report
30/1/202413:00PRNUSIterum Therapeutics Announces Positive Topline Results from..
29/12/202322:30EDGAR2Form 8-K - Current report
14/12/202313:45EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/12/202313:30EDGAR2Form DEF 14A - Other definitive proxy statements
04/12/202323:15EDGAR2Form PRE 14A - Other preliminary proxy statements
04/12/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:30EDGAR2Form 8-K - Current report
04/12/202314:00GLOBEIterum Therapeutics Regains Compliance with Nasdaq Bid Price..
07/11/202314:30GLOBEIterum Therapeutics to Provide Business Update and Report..
24/10/202315:00EDGAR2Form 8-K - Current report
24/10/202314:00GLOBEIterum Therapeutics Announces Completion of Enrollment in..
12/10/202315:15GLOBEIterum Therapeutics to Present Data at IDWeek 2023
11/8/202313:15EDGAR2Form 8-K - Current report
11/8/202313:00GLOBEIterum Therapeutics Reports Second Quarter 2023 Financial..
04/8/202323:00GLOBEIterum Therapeutics to Provide Business Update and Report..
01/8/202322:16EDGAR2Form 8-K - Current report
13/7/202313:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/7/202315:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/7/202315:24EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
Apertura: Min: Max:
Chiusura: 1,13

La tua Cronologia

NASDAQ
ITRM
Iterum Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network